Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Developing a Personalized Prediction Model for Symptom Burden in Patients with Gastrointestinal Malignancies
FY 2023-24
Summary
Cancer is a leading cause of death globally, with gastrointestinal (GI) cancer accounting for 1/3 of cancer-related deaths. Cancer diagnosis and treatment can cause significant physical and emotional distress, which if not appropriately addressed, can lead to diminished quality of life.
In Ontario, Canada, Patient-Reported Outcomes are collected by Cancer Care Ontario on an opportunistic basis using the Edmonton Symptom Assessment System (ESAS), a validated screening tool developed in the oncology population to identify the presence and severity of cancer-associated symptoms. Timely identification and appropriate management of patient reported symptoms has been shown to improve patient's quality of life and overall survival as it promotes patient-centered care, a core component of cancer care. Studies have shown that cancer patients have a limited understanding of their future/expected symptom burden, with many patients reluctant to undergo treatment such as chemotherapy due to fears that symptoms will get worse.
The objective of this project is to develop and validate a prediction model that can help provide patients with GI cancer with real-world data on symptom burden, such that patients can make the most informed decisions towards their treatment plan. We also hope to help patients understand and appreciate when their symptom burden is outside of the expected range such that appropriate supportive measures are sought out. We hypothesize that various demographic, cancer specifics, and treatment factors will significantly influence the symptom burden experienced by adult patients with GI cancer.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506544
Name
Zhu Alice
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Developing a Personalized Prediction Model for Symptom Burden in Patients with Gastrointestinal Malignancies
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Esas; General Surgery; Nomogram; Patient Outcomes; Prediction Model; Prom; Surgery; Surgical Oncology; Symptom
Abstract
Cancer is a leading cause of death globally, with gastrointestinal (GI) cancer accounting for 1/3 of cancer-related deaths. Cancer diagnosis and treatment can cause significant physical and emotional distress, which if not appropriately addressed, can lead to diminished quality of life.
In Ontario, Canada, Patient-Reported Outcomes are collected by Cancer Care Ontario on an opportunistic basis using the Edmonton Symptom Assessment System (ESAS), a validated screening tool developed in the oncology population to identify the presence and severity of cancer-associated symptoms. Timely identification and appropriate management of patient reported symptoms has been shown to improve patient's quality of life and overall survival as it promotes patient-centered care, a core component of cancer care. Studies have shown that cancer patients have a limited understanding of their future/expected symptom burden, with many patients reluctant to undergo treatment such as chemotherapy due to fears that symptoms will get worse.
The objective of this project is to develop and validate a prediction model that can help provide patients with GI cancer with real-world data on symptom burden, such that patients can make the most informed decisions towards their treatment plan. We also hope to help patients understand and appreciate when their symptom burden is outside of the expected range such that appropriate supportive measures are sought out. We hypothesize that various demographic, cancer specifics, and treatment factors will significantly influence the symptom burden experienced by adult patients with GI cancer.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhu, Alice
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~